Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mazda Adli

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Deutsches Arzteblatt International|July 7, 2009
Treatment of depressive disordersTom Bschor, Mazda Adli
Lancet (London, England)|April 25, 2014
Do we underestimate the benefits of antidepressants?Mazda Adli, Ulrich Hegerl
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|July 9, 2020
[Does the city make us ill? The effect of urban stress on emotions, behavior, and mental health]Mazda Adli, Jonas Schöndorf
MMW Fortschritte Der Medizin|March 26, 2010
[Residual symptoms after acute major depressive disorder]Claudia Lange, Mazda Adli
Deutsches Arzteblatt International|July 11, 2015
In ReplyTom Bschor, Michael Bauer, Mazda Adli
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 29, 2017
Tranylcypromine in mind (Part I): Review of pharmacologySven Ulrich, Roland Ricken, Mazda Adli
Deutsches Arzteblatt International|December 4, 2014
Chronic and treatment resistant depression: diagnosis and stepwise therapyTom Bschor, Michael Bauer, Mazda Adli
International Journal of Clinical Pharmacology and Therapeutics|September 3, 2013
Antidepressant treatment with MAO-inhibitors during general and regional anesthesia: a review and case report of spinal anesthesia for lower extremity surgery without discontinuation of tranylcypromineIlana Krings-Ernst, Sven Ulrich, Mazda Adli
Biological Psychiatry|June 14, 2006
Algorithms and collaborative-care systems for depression: are they effective and why? A systematic reviewMazda Adli, Michael Bauer, A John Rush
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 6, 2017
Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depressionRoland Ricken, Sven Ulrich, Peter Schlattmann, et al.
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Deutsches Arzteblatt International|July 7, 2009
Treatment of depressive disordersTom Bschor, Mazda Adli
Lancet (London, England)|April 25, 2014
Do we underestimate the benefits of antidepressants?Mazda Adli, Ulrich Hegerl
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|July 9, 2020
[Does the city make us ill? The effect of urban stress on emotions, behavior, and mental health]Mazda Adli, Jonas Schöndorf
MMW Fortschritte Der Medizin|March 26, 2010
[Residual symptoms after acute major depressive disorder]Claudia Lange, Mazda Adli
Deutsches Arzteblatt International|July 11, 2015
In ReplyTom Bschor, Michael Bauer, Mazda Adli
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 29, 2017
Tranylcypromine in mind (Part I): Review of pharmacologySven Ulrich, Roland Ricken, Mazda Adli
Deutsches Arzteblatt International|December 4, 2014
Chronic and treatment resistant depression: diagnosis and stepwise therapyTom Bschor, Michael Bauer, Mazda Adli
International Journal of Clinical Pharmacology and Therapeutics|September 3, 2013
Antidepressant treatment with MAO-inhibitors during general and regional anesthesia: a review and case report of spinal anesthesia for lower extremity surgery without discontinuation of tranylcypromineIlana Krings-Ernst, Sven Ulrich, Mazda Adli
Biological Psychiatry|June 14, 2006
Algorithms and collaborative-care systems for depression: are they effective and why? A systematic reviewMazda Adli, Michael Bauer, A John Rush
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 6, 2017
Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depressionRoland Ricken, Sven Ulrich, Peter Schlattmann, et al.
Pageof 13